DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms
O Abdel-Wahab, A Pardanani, R Rampal, TL Lasho… - Leukemia, 2011 - nature.com
O Abdel-Wahab, A Pardanani, R Rampal, TL Lasho, RL Levine, A Tefferi
Leukemia, 2011•nature.com3 Carbuccia N, Murati A, Trouplin V, Brecqueville M, Adélaıde J, Rey J et al. Mutations of
ASXL1 gene in myeloproliferative neoplasms. Leukemia 2009; 23: 2183–2186. 4 Oh ST,
Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs Jr KD et al. Novel mutations in the
inhibitory adaptor protein LNK drive JAKSTAT signaling in patients with myeloproliferative
neoplasms. Blood 2010; 116: 988–992.
ASXL1 gene in myeloproliferative neoplasms. Leukemia 2009; 23: 2183–2186. 4 Oh ST,
Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs Jr KD et al. Novel mutations in the
inhibitory adaptor protein LNK drive JAKSTAT signaling in patients with myeloproliferative
neoplasms. Blood 2010; 116: 988–992.
3 Carbuccia N, Murati A, Trouplin V, Brecqueville M, Adélaıde J, Rey J et al. Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia 2009; 23: 2183–2186. 4 Oh ST, Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs Jr KD et al. Novel mutations in the inhibitory adaptor protein LNK drive JAKSTAT signaling in patients with myeloproliferative neoplasms. Blood 2010; 116: 988–992.
nature.com
